YORK: Watson Pharmaceuticals, the world’s fifth-largest generic drugmaker, lifted its full-year earnings forecast as it benefits from a generic version of the big-selling Lovenox blood clot prevention drug. Watson also stood by its target of increasing...

Pharmaceuticals Inc. The companies are seeking to get the candidate approved for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy. The transfer does...

Pharmaceuticals Incorporated (NYSE: WPI) was upgraded by Buckingham Research from a “neutral” rating to a “buy” rating in a research note issued on Wednesday. Separately, analysts at Goldman Sachs (NYSE: GS) cut their EPS estimates on shares of Watson...

S&P 500 fell -0.09% or just over 1 point to 1,350.5. Earnings reports since markets closed last night have led to some price changes as of the last half hour of trading today: Avon Products Inc. (NYSE: AVP) is up 1.2% at $17.74; Goodyear Tire & Rubber Co.

ImagesWatson's generic version of Lipitor helped to boost the company's fourth quarter earnings. Generic drugmaker Watson Pharmaceuticals said its profit surged in the fourth quarter as it began selling a low-cost version of the cholesterol drug Lipitor.

What are your thoughts on that? Well, I'm going to let Fred answer that, but I think I'll just say -- I'll start with saying that I think it was a good first step, but it was simply a first step. Fred? Yes, so actually we have a nice opportunity to...